Wearable Devices for Long COVID: Prospects, Challenges and Options

IF 1.3 Q3 ETHICS Asian Bioethics Review Pub Date : 2024-01-20 DOI:10.1007/s41649-023-00272-3

Hui Yun Chan

引用次数: 0

Abstract

Post COVID-19 infections resulting in long COVID symptoms remain persistent yet neglected in healthcare priorities. Although long COVID symptoms are expected to decline after some time, many people continue to endure its debilitating effects affecting their daily lives. The diversity of characteristics amongst long COVID patients adds to the complexity of communicating personal health predicaments to healthcare providers. Recent research towards building an evidence base for long COVID with the aim of delivering responsive healthcare interventions for long COVID patients has utilised datasets generated from wearable devices. This paper examines the prospects presented by wearable devices for long COVID patients and physicians. It highlights distinct ethical and legal challenges arising from their use in practice. Several recommendations aiming to support their usage amongst long COVID patients are outlined for future research using wearable devices for long COVID treatment.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

用于长 COVID 的可穿戴设备：前景、挑战和选择

COVID-19 后感染导致的长期 COVID 症状仍然持续存在，但却被医疗保健优先事项所忽视。尽管长COVID症状在一段时间后会有所缓解，但许多人仍在忍受其对日常生活造成的衰弱影响。长期慢性阻塞性肺气肿患者的特征多种多样，这增加了与医疗服务提供者沟通个人健康困境的复杂性。为建立长期慢性阻塞性肺病的证据基础，以便为长期慢性阻塞性肺病患者提供有针对性的医疗干预措施，最近的研究利用了可穿戴设备生成的数据集。本文探讨了可穿戴设备为长期慢性阻塞性肺病患者和医生带来的前景。它强调了在实践中使用可穿戴设备所面临的伦理和法律挑战。本文概述了几项建议，旨在支持将可穿戴设备用于长期慢性阻塞性肺病治疗的未来研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Asian Bioethics Review Multiple-

CiteScore

6.20

自引率

3.40%

发文量

期刊介绍： Asian Bioethics Review (ABR) is an international academic journal, based in Asia, providing a forum to express and exchange original ideas on all aspects of bioethics, especially those relevant to the region. Published quarterly, the journal seeks to promote collaborative research among scholars in Asia or with an interest in Asia, as well as multi-cultural and multi-disciplinary bioethical studies more generally. It will appeal to all working on bioethical issues in biomedicine, healthcare, caregiving and patient support, genetics, law and governance, health systems and policy, science studies and research. ABR provides analyses, perspectives and insights into new approaches in bioethics, recent changes in biomedical law and policy, developments in capacity building and professional training, and voices or essays from a student’s perspective. The journal includes articles, research studies, target articles, case evaluations and commentaries. It also publishes book reviews and correspondence to the editor. ABR welcomes original papers from all countries, particularly those that relate to Asia. ABR is the flagship publication of the Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore. The Centre for Biomedical Ethics is a collaborating centre on bioethics of the World Health Organization.